COMMUNIQUÉS West-GlobeNewswire

Medigene AG reports Financial Results and Business Update for Q1 2024
26/04/2024
Planegg/Martinsried, April 26, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid [...]
PCI Biotech Holding ASA - Annual Report 2023
26/04/2024
Oslo, Norway, April 26, 2024. The Board of Directors of PCI Biotech Holding ASA has approved the Annual Report 2023. Please find the report attached, as well as the report according to the European Single Electronic [...]
Nexstim Plc Business Update Q1 2024
26/04/2024
Press release, Helsinki, 26 April 2024 at 9 AM (EEST) Nexstim Plc Business Update Q1 2024 Nexstim Plc (NXTMH:HEX) (”Nexstim” or ”Company”) announces the key highlights of the Company’s business operations during Q1 2024 [...]
Burning Rock Announces ADS Ratio Change
26/04/2024
GUANGZHOU, China, April 26, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) [...]
JERAYGO (aprocitentan) recommended for approval in Europe for the treatment of resistant hypertension
26/04/2024
Ad hoc announcement pursuant to Art. 53 LR Idorsia receives a positive opinion from the Committee for Medicinal Products for Human Use for JERAYGO™ (aprocitentan) as the first and only endothelin receptor antagonist for [...]
Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants
26/04/2024
PALO ALTO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced the pricing of an underwritten public offering of (i) 6,000,000 shares of its common stock and accompanying [...]
Belite Bio Announces $25 Million Registered Direct Offering
26/04/2024
SAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- Belite Bio , Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics [...]
Intuitive Announces Board of Directors Elections and Retirements
26/04/2024
Lewis Chew elected to Intuitive’s Board Alan Levy, PhD and Don Kania, PhD to retire from Board SUNNYVALE, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Intuitive (Nasdaq: ISRG), a global technology leader in minimally [...]
Altimmune Statement on the Passing of Dr. Stephen Harrison
25/04/2024
GAITHERSBURG, Md., April 25, 2024 (GLOBE NEWSWIRE) -- The Altimmune team would like to express our sorrow and extend our heartfelt condolences to Dr. Stephen Harrison’s family following his tragic and unexpected passing [...]
Aesthetic Medical International Holdings Group Ltd. Announces Receipt of Decision from the Nasdaq Hearings Panel for Conditional Continued Listing
25/04/2024
Shenzhen, China, April 25, 2024 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today [...]
Ascendis Pharma to Report First Quarter 2024 Financial Results and Provide Business Update on May 2, 2024
25/04/2024
COPENHAGEN, Denmark, April 25, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it will report first quarter 2024 financial results and provide a business update on Thursday, May 2, 2024, [...]
Tilray Brands Celebrates Big Wins at the Craft Brewer’s Conference and 2024 World Beer Cup, the Most Prestigious Beer Competition in the World
25/04/2024
10 Barrel Brewing Wins Innovation in Craft Brewing Award and Sweeps German-Style Sour Ale Category with Gold, Silver, and Bronze Medals Green Flash Brewing Wins Bronze in Juicy or Hazy Pale Ale Category NEW YORK, April [...]
Ultragenyx to Host Conference Call for First Quarter 2024 Financial Results and Corporate Update
25/04/2024
NOVATO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and [...]
Combined General Meeting of May 16, 2024
25/04/2024
Châtillon, France, April 25, 2024 Combined General Meeting of May 16, 2024 Procedures for Obtaining Information and Preparatory Documents for the Combined General Meeting DBV Technologies (Euronext: DBV – ISIN: [...]
Assemblée Générale Mixte du 16 mai 2024
25/04/2024
Châtillon, France, le 25 avril 2024 Assemblée Générale Mixte du 16 mai 2024 Modalités de mise à disposition des informations et documents préparatoires à l’Assemblée Générale Mixte DBV Technologies (Euronext : DBV – [...]
Cronos Group Inc. to Hold 2024 First Quarter Earnings Conference Call on May 9, 2024
25/04/2024
TORONTO, April 25, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2024 first quarter earnings conference call on Thursday, May 9, 2024 at 8:30 a.m. ET. [...]
ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update
25/04/2024
ARCA biopharma and Oruka Therapeutics announce Merger Agreement ARCA biopharma appoints Thomas Keuer as President WESTMINSTER, Colo., April 25, 2024 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), (the “Company [...]
GENFIT: Publication of the 2024 Extra-Financial Performance Report (fiscal year 2023)
25/04/2024
Lille (France), Cambridge (Massachusetts, USA), Zurich (Switzerland), April 25, 2024 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company committed to improving the lives of patients with rare, [...]
GENFIT : Publication du rapport de performance extra-financière 2024 (exercice 2023)
25/04/2024
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 25 avril 2024 – GENFIT (Nasdaq et Euronext: GNFT) , société biopharmaceutique de stade clinique avancé engagée dans l’amélioration de la vie des [...]

Pages